Innate Pharma (PK) Stock Quote IPHYF - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.90

Bid

1.65

Ask

2.91

Volume

0.00 Day's Range 0.00

1.28 52 Week Range 2.90

Market Cap

922.694M

Previous Close

2.90

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,650

Shares Outstanding

318,170,508

Dividend Yield

PE Ratio

-84.87

Earnings Per Share (EPS)

-0.02

Revenue

61.64M

Net Profit

-7.57M

Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by enhancing the capability of the body's own immune cells to recognize and kill cancer cells. The Company has pioneered the development of antibodies that block inhibitory checkpoint receptors on... Innate Pharma specializes in immuno-oncology, a new therapeutic field that is changing cancer treatment by enhancing the capability of the body's own immune cells to recognize and kill cancer cells. The Company has pioneered the development of antibodies that block inhibitory checkpoint receptors on NK cells. Today, Innate Pharma has three first-in-class antibodies in clinical development in immuno-oncology and a pipeline of preclinical candidates to novel targets and mechanisms. Its innovative approach has translated into alliances with leaders in the biopharmaceutical industry such as AstraZeneca, Bristol-Myers Squibb, Novo Nordisk A/S and Sanofi. Based in Marseille, France, Innate Pharma had 122 employees as at March 31, 2016. The company is listed on Euronext Paris. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

Innate Pharma (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker IPHYF. The last closing price for Innate Pharma (PK) was $2.90. Over the last year, Innate Pharma (PK) shares have traded in a share price range of $ 1.28 to $ 2.90.

Innate Pharma (PK) currently has 318,170,508 shares outstanding. The market capitalization of Innate Pharma (PK) is $922.69 million. Innate Pharma (PK) has a price to earnings ratio (PE ratio) of -84.87.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0.81	38.7559808612	2.09	2.9	2.09	1650	2.9	CS
26	0.7	31.8181818182	2.2	2.9	1.28	825	2.42484848	CS
52	0.38	15.0793650794	2.52	2.9	1.28	1206	2.33200864	CS
156	-0.56	-16.1849710983	3.46	3.75	1.28	969	2.53035417	CS
260	-4.28	-59.6100278552	7.18	11	1.28	1551	4.68850852	CS

IPHYF - Frequently Asked Questions (FAQ)

What is the current Innate Pharma (PK) share price?

The current share price of Innate Pharma (PK) is $ 2.90

How many Innate Pharma (PK) shares are in issue?

Innate Pharma (PK) has 318,170,508 shares in issue

What is the market cap of Innate Pharma (PK)?

The market capitalisation of Innate Pharma (PK) is USD 922.69M

What is the 1 year trading range for Innate Pharma (PK) share price?

Innate Pharma (PK) has traded in the range of $ 1.28 to $ 2.90 during the past year

What is the PE ratio of Innate Pharma (PK)?

The price to earnings ratio of Innate Pharma (PK) is -84.87

What is the cash to sales ratio of Innate Pharma (PK)?

The cash to sales ratio of Innate Pharma (PK) is 10.43

What is the reporting currency for Innate Pharma (PK)?

Innate Pharma (PK) reports financial results in EUR

What is the latest annual turnover for Innate Pharma (PK)?

The latest annual turnover of Innate Pharma (PK) is EUR 61.64M

What is the latest annual profit for Innate Pharma (PK)?

The latest annual profit of Innate Pharma (PK) is EUR -7.57M

What is the registered address of Innate Pharma (PK)?

The registered address for Innate Pharma (PK) is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma (PK) website address?

The website address for Innate Pharma (PK) is www.innate-pharma.com

Which industry sector does Innate Pharma (PK) operate in?

Innate Pharma (PK) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIHGeneral Steel Holdings Inc (CE)	$ 0.10 (99,900.00%)	25.32k
AFIIQArmstrong Flooring Inc (CE)	$ 0.0002 (19,900.00%)	300
IVRNInnoveren Scientific Inc (CE)	$ 0.0002 (19,900.00%)	10k
EXBXExobox Technologies Corp (CE)	$ 0.0001 (9,900.00%)	123.89k
ACAISafeplus International Holdings Ltd (CE)	$ 0.0001 (9,900.00%)	2.08k
TBLTToughBuilt Industries Inc (CE)	$ 0.000001 (-100.00%)	487
GNRSQGreenrose Holding Company Inc (CE)	$ 0.000001 (-100.00%)	261
ELOXEloxx Pharmaceuticals Inc (CE)	$ 0.0001 (-99.99%)	2.53k
TIGXFTeam Internet Group PLC (QX)	$ 0.0001 (-99.99%)	100
BLIBQBB Liquidating Inc (CE)	$ 0.000001 (-99.90%)	25k
GTVHGolden Triangle Ventures Inc (PK)	$ 0.00035 (40.00%)	258.92M
HMBLHUMBL Inc (PK)	$ 0.0005 (0.00%)	221.36M
GRPSGold River Productions Inc (PK)	$ 0.0002 (-20.00%)	205.71M
TSOITherapeutic Solutions International Inc (PK)	$ 0.0002 (-33.33%)	201.87M
AITXArtificial Intelligence Technology Solutions Inc (PK)	$ 0.0025 (-3.85%)	187.8M